Palliative Chemotherapy or Watchful Waiting? A Vignettes Study Among Oncologists
- 1 September 2002
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (17) , 3658-3664
- https://doi.org/10.1200/jco.2002.12.012
Abstract
PURPOSE: To determine the preferences of oncologists for palliative chemotherapy or watchful waiting and the factors considered important to that preference. METHODS: Sixteen vignettes (paper case descriptions), varying on eight patient and treatment characteristics, were designed to assess the oncologists’ preferences. Their strength of preference was rated on a 7-point scale. An orthogonal main effects design provided a subset of all possible combinations of the characteristics, allowing estimations of the relative weights of the presented characteristics. A written questionnaire was sent to a random sample of oncologists (N = 1,235). RESULTS: The response rate was 67%, and 697 questionnaires were available for analysis. Eighty-one percent of the respondents were male. The mean age was 46 years. We found considerable variation among the oncologists. No major associations between physician characteristics and preferences were found. Of the patient and treatment characteristics affecting treatment preference, age was the strongest predictor, followed by the patient’s wish to be treated and the expected survival gain. Other patient and treatment characteristics had a limited effect on preferences, except for psychologic distress, which had no independent impact. CONCLUSION: Patients will encounter different decisions depending on their oncologists’ preferences and their own personal background. Therefore, to ensure adequate information for decision-making processes, decision aids are proposed.Keywords
This publication has 41 references indexed in Scilit:
- Topotecan Versus Observation After Cisplatin Plus Etoposide in Extensive-Stage Small-Cell Lung Cancer: E7593—A Phase III Trial of the Eastern Cooperative Oncology GroupJournal of Clinical Oncology, 2001
- Does Palliative Chemotherapy Palliate? Evaluation of Expectations, Outcomes, and Costs in Women Receiving Chemotherapy for Advanced Ovarian CancerJournal of Clinical Oncology, 2001
- PubMed Central: creating an Aladdin's cave of ideasBMJ, 2001
- Palliative Effect of Chemotherapy: Objective Tumor Response Is Associated With Symptom Improvement in Patients With Metastatic Breast CancerJournal of Clinical Oncology, 2000
- Do patients with advanced breast cancer benefit from chemotherapy?British Journal of Cancer, 1998
- Responsiveness to Change in Health-Related Quality of Life in a Randomized Clinical Trial: A Comparison of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) with Analogous Scales from the EORTC QLQ-C30 and a Trial Specific ModuleJournal of Clinical Epidemiology, 1998
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Childhood acute lymphoblastic leukaemiaEuropean Journal Of Cancer, 1997
- Goals of palliative cancer therapy.Journal of Clinical Oncology, 1993
- Goals of palliative cancer therapy: scope of the problemCancer Treatment Reviews, 1993